Nicolas G. Kint

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Belgian recommendations for tissue diagnosis of amyloidosis.

Belgian recommendations for tissue diagnosis of amyloidosis.

Journal: Acta clinica Belgica

Published: April 27, 2026

Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patients.

Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patients.

Journal: Annals of hematology

Published: March 25, 2026

Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study.

Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study.

Journal: The American journal of clinical nutrition

Published: March 14, 2026

Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study.

Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study.

Journal: The American journal of clinical nutrition

Published: March 14, 2026

Effective front-line treatment of osteosclerotic myeloma with POEMS syndrome with daratumumab, lenalidomide and dexamethasone: a case report and literature review.

Effective front-line treatment of osteosclerotic myeloma with POEMS syndrome with daratumumab, lenalidomide and dexamethasone: a case report and literature review.

Journal: Acta clinica Belgica

Published: December 12, 2025

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

Journal: The New England journal of medicine

Published: February 12, 2025

Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging.

Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging.

Journal: Insights into imaging

Published: February 15, 2024

Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients.

Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients.

Journal: OncoTargets and therapy

Published: October 16, 2021

Immunomodulators in newly diagnosed multiple myeloma: current and future concepts.

Immunomodulators in newly diagnosed multiple myeloma: current and future concepts.

Journal: Expert review of hematology

Published: March 18, 2021

Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation.

Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation.

Journal: Leukemia

Published: April 15, 2019

Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes.

Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes.

Journal: Nature communications

Published: May 15, 2017

Concise review - Treatment of multiple myeloma in the very elderly: How do novel agents fit in?

Concise review - Treatment of multiple myeloma in the very elderly: How do novel agents fit in?

Journal: Journal of geriatric oncology

Published: February 04, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026